[18F]FDG-PET-CT compared with CT for persistent or recurrent neutropenic fever in high-risk patients (PIPPIN): a multicentre, open-label, phase 3, randomised, controlled trial

Resource type
Journal Article
Authors/contributors
Title
[18F]FDG-PET-CT compared with CT for persistent or recurrent neutropenic fever in high-risk patients (PIPPIN): a multicentre, open-label, phase 3, randomised, controlled trial
Publication
The Lancet Haematology
Date
2022-08-01
Volume
9
Issue
8
Pages
e573-e584
Journal Abbr
The Lancet Haematology
Accessed
9/22/22, 9:03 AM
ISSN
2352-3026
Short Title
[18F]FDG-PET-CT compared with CT for persistent or recurrent neutropenic fever in high-risk patients (PIPPIN)
Language
English
Library Catalog
Extra
Publisher: Elsevier PMID: 35777413
Citation
Douglas, A., Thursky, K., Spelman, T., Szer, J., Bajel, A., Harrison, S., Tio, S. Y., Bupha-Intr, O., Tew, M., Worth, L., Teh, B., Chee, L., Ng, A., Carney, D., Khot, A., Haeusler, G., Yong, M., Trubiano, J., Chen, S., … Slavin, M. (2022). [18F]FDG-PET-CT compared with CT for persistent or recurrent neutropenic fever in high-risk patients (PIPPIN): a multicentre, open-label, phase 3, randomised, controlled trial. The Lancet Haematology, 9(8), e573–e584. https://doi.org/10.1016/S2352-3026(22)00166-1
DIAGNOSTICS
HEME-ONC AND CELLULAR THERAPIES
Link to this record